Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

161.71 USD -0.16 (-0.10%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Nasdaq Biotechnology Ishares ETF

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Has the Market Baked a Mud Pie or Fudge Cake?
Our Granddad Russell 2000, which ended last week managed to hang onto the 50 daily moving average. If you hope to lick the mixing spoon, it’s this index that gives you the best chance for a sweet... 
Tags ETF's
From Blogs - TalkMarkets
Large Cap Biopharmaceuticals-Valuation Models 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations. 
Tags Stocks / Equities ETF's Pharma/Biotech
From Blogs - TalkMarkets
Pockets Filled With Gold
Last week’s market saw its own version of a gold rush. Cash gold ended above the 200 week moving average for the second week in a row. The last time it traded above that moving average was in April... 
Tags Commodities Gold/Precious Metals Stocks / Equities
From Blogs - TalkMarkets
Utilities, Anyone?
The celebratory nature of the stock market is being masked by another telling trend: Defensive sectors are outperforming higher risk areas. 
Tags Stocks / Equities Utilities ETF's
From Blogs - TalkMarkets
Fast Money Traders Share Their Biotech Picks
On CNBC's Fast Money Final Trade, Tim Seymour said that Gilead Sciences, Inc. (NASDAQ: GILD) looks cheap at 7 times price-to-earnings ... 
Tags GILD Guy Adami IBB
From Benzinga
Traders spot relative value in biotech
The iShares NASDAQ Biotechnology ETF was up more than 3 percent on the week, but down nearly 24 percent this year. 
Tags Pfizer Inc Investing Biotechnology
From CNBC.com News
The Best Seasonal Investments For Q3
Bonds and defensive baskets offer the strongest seasonal tailwinds in Q3.The best industries for Q3 seasonality are biotech, healthcare providers, and software. 
Tags ETF's Bonds
From Blogs - TalkMarkets
Vista Partners Initiates Coverage on Mount TAM Biotechnologies, Inc. (Ticker: MNTM); $3.25 Price Target
From Marketwired News Releases
BRexit Bottom For Biotech Creates Buying Opportunity
Biotech stocks soared yesterday getting relief from the brutal BRexit bashing that scared away all buyers. BRexit has little to do with biopharma but the”risk-off” pall brings caution and a move to... 
Tags ETF's Stocks / Equities Healthcare
From Blogs - TalkMarkets
Don't Put Away Your Umbrella Just Yet
Yesterday’s potential reversal pattern in its current Bearish phase confirmed today. QQQs ran up to the January 13th high the day it opened higher and then proceeded to tank. It also ran slightly above... 
Tags Pharma/Biotech Gold/Precious Metals ETF's
From Blogs - TalkMarkets
How Do I Turn Off All The Noise?
As I went through the tweets of those I follow before the market opened today, I literally felt like my head could explode. Opinions, opinions, opinions and more opinions. 
Tags ETF's Stocks / Equities Currencies/Forex
From Blogs - TalkMarkets
Brexit: A Bane for Bumbling Biotech ETFs?
Brexit is the excuse of the moment that many market observers are pointing to explain the near-term struggles of various asset classes and sectors. In some cases, that observation is accurate. In... 
Tags featured biotech IBB
From ETF Trends
Brexit brings an opportunity to reload the portfolio
Assuming that a few of our favorite names take a hit this morning, we should be able to pick up some shares at a nice discount, which is the smart play when investors are panicking. 
Tags FIT Telecommunications IBB
From MarketWatch
The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery
 
Tags NASDAQ:IBB NASDAQ:CELG NASDAQ:BIIB
From InvestorPlace
Analysts Anticipate IBB Will Reach $359
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Best Stock Charts - June 23, 2016
We talk about the latest market overview by reviewing different charts. 
Tags Stocks / Equities Energy Currencies/Forex
From Blogs - TalkMarkets
The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!
 
Tags Trading Advice NASDAQ:IBB
From InvestorPlace
Sharp Biotech Reversal To Upside Today: IBB Up 2.40%…Update-1
The IBB peaked at $260 and dropped back to settle at $256.56 up only 0.56%. 
Tags ETF's Stocks / Equities Healthcare
From Blogs - TalkMarkets
Biotech stocks surge as Medicare report relieves worries
Biotech stocks rallied after a government report said that Medicare cost-cutting measures will not be triggered this year. 
Tags Investing Celgene Corp iShares Nasdaq Biotechnology ETF
From CNBC.com News
Here Is Why Biotech Stocks Just Exploded Higher
On the back of extremely heavy volume, Biotech and Pharma stocks soared moments ago, following yesterday's surprising weakness. What was the catalyst? 
Tags ETF's Stocks / Equities Healthcare
From Blogs - TalkMarkets
Biotechs Are Ripping Following IPAB Ruling
Biotech stocks spiked higher on Wednesday after the U.S. government said that Medicare will be exhausted in 2028, two years sooner ... 
Tags News AMGN ACAD
From Benzinga
Troubling Technical News for Biotech ETFs
Already under significant pressure, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotech exchange traded funds face a predictable result... 
Tags featured IBB SBIO
From ETF Trends
Bio Tech - Market Leadership Testing Breakdown Level
Bio-Tech IBB could be forming a “Bearish Descending Triangle. Bio-Tech was tons stronger than the broad markets from 2011 to 2015. 
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Biotech ETFs Reeling in Longest Sector Selloff in Two Decades
Biotechnology-related exchange traded funds are stuck in a malaise, with the underlying biotech sector declining for the ninth consecutive session, its longest selloff in a twenty years. Since June 6,... 
Tags IBB BIIB Biotechnology
From ETF Trends
Biotech Bloodbath: Ditch XBI, IBB for Now
 
Tags NASDAQ:IBB NYSE:VRX Trading Advice
From InvestorPlace
Expect More Election Year Volatility For Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have disappointed investors for close to a year. Unfortunately, election... 
Tags IBB XBI FBT
From ETF Trends
Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More 
From Marketwired News Releases
ETF TMI: Strategy Shares Debuts Two ETFs; Global Markets on Fire
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… Strategy Shares Debuts with Two Actively Managed ETFs Strategy Shares on Thursday announced its launch,... 
Tags XBI IBB HYG
From ETF Trends
Biotech Blahs: Unable To Hold Gains After ASCO Run-Up
As of midday trading Friday biotech stocks are trading down near the May lows erasing gains from the ASCO run-up. Nonetheless, there is plenty of interest in the sector with tons of cash waiting in the... 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Follow Icahn Into Allergan Stock
Carl Icahn has just declared that he has invested a mint into Allergan. Investors should follow suit and when the Teva deal goes through, Allergan will have a cool $20 billion extra in liquidity to... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.